Heard during Procter & Gamble's (PG -4.8%) earnings call: 1) The company admits some missteps in emerging markets by expanding too quickly in key product areas. 2) On market share, while U.S. and China look strong, execs admit that it has pockets around the world where it's slipping. Beauty and skin care is mentioned as an under-performing category. 3) Competitive launches by rivals seem to have impacted results, but the company maintains new innovation (pet care, Duracell, etc.) will help it take back market share. 4) P&G sees buying back $6B in stock this year, at the high end of its previous forecast. (webcast) [View news story]
This stock is a cash machine with some of the best brands in the world. I'm long PG
Procter & Gamble (PG +0.4%) and Teva Pharmaceuticals (TEVA +0.1%) break ground on a new $90M plant in India through their joint venture in the region. The new plant will support the growing demand in Asia for non-prescription health care products. [View news story]
I've always liked P&G since visiting a plant when I was 7
Heard during Procter & Gamble's (PG -4.8%) earnings call: 1) The company admits some missteps in emerging markets by expanding too quickly in key product areas. 2) On market share, while U.S. and China look strong, execs admit that it has pockets around the world where it's slipping. Beauty and skin care is mentioned as an under-performing category. 3) Competitive launches by rivals seem to have impacted results, but the company maintains new innovation (pet care, Duracell, etc.) will help it take back market share. 4) P&G sees buying back $6B in stock this year, at the high end of its previous forecast. (webcast) [View news story]
Canaccord Genuity starts coverage on Procter & Gamble (PG) with a Buy rating and $87 price target. [View news story]
Procter & Gamble (PG +0.4%) and Teva Pharmaceuticals (TEVA +0.1%) break ground on a new $90M plant in India through their joint venture in the region. The new plant will support the growing demand in Asia for non-prescription health care products. [View news story]
Notable earnings before Thursday’s open: ABB, AET, AUO, AVT, AZN, BEN, BG, BIIB, CAB, CCE, CELG, CL, CME, CMS, CNX, COP, CRR, CS, CVE, D, DBD, DDD, DNKN, EQT, GG, GTI, HERO, HOT, HSY, IMAX, IP, JBLU, JNS, LINE, LKQ, MCK, MJN, MO, MYL, NBL, NOV, NS, NVS, NXPI, NYT, O, ORI, OXY, PCAR, PCP, PDS, PG, PHM, POT, PTEN, RCL, ROC, RTN, RYN, S, SHW, SPG, SWI, TKR, TSM, TZOO, UA, UAL, VLY, VPHM, XEL, ZMH [View news story]
15 stocks traders are "shorting like crazy," according to BI: TEA, HGG, BPI, BKS, GME, INVN, MCP, KBH, SVU, ESI, OSG, RSH, CRR, USNA, ONE. [View news story]